{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T09:56:36Z","timestamp":1785232596215,"version":"3.55.0"},"reference-count":76,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Up to 10 million people per annum experience traumatic brain injury (TBI), 80\u201390% of which are categorized as mild. A hit to the brain can cause TBI, which can lead to secondary brain injuries within minutes to weeks after the initial injury through unknown mechanisms. However, it is assumed that neurochemical changes due to inflammation, excitotoxicity, reactive oxygen species, etc., that are triggered by TBI are associated with the emergence of secondary brain injuries. The kynurenine pathway (KP) is an important pathway that gets significantly overactivated during inflammation. Some KP metabolites such as QUIN have neurotoxic effects suggesting a possible mechanism through which TBI can cause secondary brain injury. That said, this review scrutinizes the potential association between KP and TBI. A more detailed understanding of the changes in KP metabolites during TBI is essential to prevent the onset or at least attenuate the severity of secondary brain injuries. Moreover, this information is crucial for the development of biomarker\/s to probe the severity of TBI and predict the risk of secondary brain injuries. Overall, this review tries to fill the knowledge gap about the role of the KP in TBI and highlights the areas that need to be studied.<\/jats:p>","DOI":"10.3389\/fneur.2023.1210453","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T05:14:16Z","timestamp":1686287656000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["The kynurenine pathway in traumatic brain injuries and concussion"],"prefix":"10.3389","volume":"14","author":[{"given":"Mona","family":"Dehhaghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Heng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles J.","family":"Guillemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S1474-4422(17)30371-X","article-title":"Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research","volume":"16","author":"Maas","year":"2017","journal-title":"Lancet Neurol."},{"key":"B2","unstructured":"\u201cTraumatic Brain Injury & Concussion,\u201dCenters for Disease Control and Prevention, National Center for Injury Prevention and Control2022"},{"key":"B3","volume-title":"Report to Congress on Mild Traumatic Brain Injury in the United States: Steps to Prevent a Serious Public Health Problem","year":"2003"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2016.84","article-title":"Traumatic brain injuries","volume":"2","author":"Blennow","year":"2016","journal-title":"Nat Rev Dis Primers."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e182853","DOI":"10.1001\/jamapediatrics.2018.2853","article-title":"Centers for Disease Control and Prevention guideline on the diagnosis and management of mild traumatic brain injury among children","volume":"172","author":"Lumba-Brown","year":"2018","journal-title":"JAMA Pediatr."},{"key":"B6","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/S1474-4422(08)70164-9","article-title":"Moderate and severe traumatic brain injury in adults","volume":"7","author":"Maas","year":"2008","journal-title":"Lancet Neurol."},{"key":"B7","article-title":"Pathophysiology of traumatic brain injury","author":"Mustafa","year":"2013","journal-title":"Neurosci J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s11916-022-01039-5","article-title":"Cognitive impairment in primary and secondary headache disorders","volume":"26","author":"Begasse De Dhaem","year":"2022","journal-title":"Curr Pain Headache Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/bja\/aem131","article-title":"Pathophysiology of traumatic brain injury","volume":"99","author":"Werner","year":"2007","journal-title":"Br J Anaesthesia."},{"key":"B10","doi-asserted-by":"publisher","first-page":"121352","DOI":"10.1016\/j.lfs.2022.121352","article-title":"NLRP3 inflammasome in traumatic brain injury: Its implication in the disease pathophysiology and potential as a therapeutic target","author":"Chakraborty","year":"2022","journal-title":"Life Sci."},{"key":"B11","author":"Mcdonald","year":"2022","journal-title":"Effect of Injury Mechanism and Severity on the Molecular Pathophysiology of Traumatic Brain Injury"},{"key":"B12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/msj.20104","article-title":"Pathophysiology of traumatic brain injury","volume":"76","author":"Greve","year":"2009","journal-title":"Mt Sinai J Med."},{"key":"B13","doi-asserted-by":"crossref","first-page":"p. 45","DOI":"10.1201\/9780367810535-4","article-title":"The pathophysiology of traumatic brain injury","volume-title":"Traumatic Brain Injury in Sports","author":"Giza","year":"2020"},{"key":"B14","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/02699050400025059","article-title":"Effects of the dopaminergic agent and NMDA receptor antagonist amantadine on cognitive function, cerebral glucose metabolism and D2 receptor availability in chronic traumatic brain injury: a study using positron emission tomography (PET)","volume":"19","author":"Kraus","year":"2005","journal-title":"Brain Injury."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1089\/neu.2005.22.1428","article-title":"The effect of the selective NMDA receptor antagonist traxoprodil in the treatment of traumatic brain injury","volume":"22","author":"Yurkewicz","year":"2005","journal-title":"J Neurotrauma."},{"key":"B16","doi-asserted-by":"publisher","first-page":"102161","DOI":"10.1016\/j.npep.2021.102161","article-title":"Long term neuroprotective effects of acute single dose MK-801treatment against traumatic brain injury in immature rats","volume":"88","author":"Cigel","year":"2021","journal-title":"Neuropeptides."},{"key":"B17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.nurt.2009.10.016","article-title":"Involvement of pro-and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury","volume":"7","author":"Ziebell","year":"2010","journal-title":"Neurotherapeutics."},{"key":"B18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nrneurol.2017.13","article-title":"The far-reaching scope of neuroinflammation after traumatic brain injury","volume":"13","author":"Simon","year":"2017","journal-title":"Nature Rev Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-015-0328-2","article-title":"Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans","volume":"12","author":"Yan","year":"2015","journal-title":"J Neuroinflammation."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e865","DOI":"10.1038\/tp.2016.133","article-title":"An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation","volume":"6","author":"Brundin","year":"2016","journal-title":"Transl Psychiatry."},{"key":"B21","doi-asserted-by":"publisher","first-page":"562812","DOI":"10.3389\/fcell.2020.562812","article-title":"The gut microbiota, kynurenine pathway, and immune system interaction in the development of brain cancer","volume":"8","author":"Dehhaghi","year":"2020","journal-title":"Front Cell Dev Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/BF03033908","article-title":"The involvement of astrocytes and kynurenine pathway in Alzheimer's disease","volume":"12","author":"Ting","year":"2007","journal-title":"Neurotox Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"204","DOI":"10.2478\/v10039-010-0023-6","article-title":"Kynurenine and its metabolites in Alzheimer's disease patients","volume":"55","author":"Gulaj","year":"2010","journal-title":"Adv Med Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s12640-009-9129-7","article-title":"The kynurenine pathway and inflammation in amyotrophic lateral sclerosis","volume":"18","author":"Chen","year":"2010","journal-title":"Neurotox Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.3390\/ijms21082665","article-title":"Cerebrospinal fluid neurofilament light chain is associated with kynurenine pathway metabolite changes in multiple sclerosis","volume":"21","author":"Rajda","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"103667","DOI":"10.1016\/j.msard.2022.103667","article-title":"Association between microglial activation and serum kynurenine pathway metabolites in multiple sclerosis patients","volume":"59","author":"Saraste","year":"2022","journal-title":"Mult Scler Relat Disord."},{"key":"B27","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1046\/j.1471-4159.2001.00498.x","article-title":"Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection","volume":"78","author":"Guillemin","year":"2001","journal-title":"J Neurochem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.4137\/IJTR.S2097","article-title":"Kynurenine pathway metabolites in humans: disease and healthy states International journal of tryptophan research","volume":"2","author":"Chen","year":"2009","journal-title":"IJTR S"},{"key":"B29","doi-asserted-by":"publisher","first-page":"0824","DOI":"10.14336\/AD.2021.0824","article-title":"The role of kynurenine pathway and NAD+ metabolism in myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"13","author":"Dehhaghi","year":"2022","journal-title":"Aging & Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/bs.ircmb.2017.07.004","article-title":"Indoleamine 2, 3-dioxygenase and its therapeutic inhibition in cancer","volume":"336","author":"Prendergast","year":"2018","journal-title":"Int Rev Cell Mol Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1178646919852996","DOI":"10.1177\/1178646919852996","article-title":"Microorganisms, tryptophan metabolism, and kynurenine pathway: a complex interconnected loop influencing human health status","volume":"12","author":"Dehhaghi","year":"2019","journal-title":"Int J Tryptophan Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1179\/135100002125000550","article-title":"Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease","volume":"7","author":"Guillemin","year":"2002","journal-title":"Redox Report."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e0131389","DOI":"10.1371\/journal.pone.0131389","article-title":"Expression of the kynurenine pathway in human peripheral blood mononuclear cells: implications for inflammatory and neurodegenerative disease","volume":"10","author":"Jones","year":"2015","journal-title":"PLoS ONE."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-2-16","article-title":"Quinolinic acid selectively induces apoptosis of human astrocytes: potential role in AIDS dementia complex","volume":"2","author":"Guillemin","year":"2005","journal-title":"J Neuroinflammation."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-6-36","article-title":"Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease","volume":"6","author":"Ting","year":"2009","journal-title":"J Neuroinflammation."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399406000068","article-title":"Tryptophan metabolism in the central nervous system: medical implications","volume":"8","author":"Ruddick","year":"2006","journal-title":"Expert Rev Mol Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: when physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nature Rev Neurosci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3389\/fneur.2019.00778","article-title":"Systematic review on the involvement of the kynurenine pathway in stroke: pre-clinical and clinical evidence","author":"Colpo","year":"2019","journal-title":"Front Neurol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.2174\/1381612822666151214125950","article-title":"The kynurenine pathway in the acute and chronic phases of cerebral ischemia","volume":"22","author":"Isabel Cuartero","year":"2016","journal-title":"Curr Pharm Des."},{"key":"B40","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12640-009-9051-z","article-title":"Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons","volume":"16","author":"Braidy","year":"2009","journal-title":"Neurotox Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1111\/j.1742-4658.2012.08485.x","article-title":"Quinolinic acid, the inescapable neurotoxin","volume":"279","author":"Guillemin","year":"2012","journal-title":"FEBS J."},{"key":"B42","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/nn1472","article-title":"ATP mediates rapid microglial response to local brain injury in vivo","volume":"8","author":"Davalos","year":"2005","journal-title":"Nat Neurosci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-020-02005-x","article-title":"Cellular infiltration in traumatic brain injury","volume":"17","author":"Alam","year":"2020","journal-title":"J Neuroinflammation."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.3390\/ijms22052439","article-title":"DAMPs and RAGE pathophysiology at the acute phase of brain injury: an overview","volume":"22","author":"Balan\u00e7a","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S0197-0186(01)00133-4","article-title":"Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes","volume":"40","author":"Tavares","year":"2002","journal-title":"Neurochem Int."},{"key":"B46","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1155\/2013\/104024","article-title":"Quinolinic acid: an endogenous neurotoxin with multiple targets","volume":"2013","author":"Lugo-Huitr\u00f3n","year":"2013","journal-title":"Oxid Med Cell Longev"},{"key":"B47","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/BF03033781","article-title":"Involvement of quinolinic acid in AIDS dementia complex","volume":"7","author":"Guillemin","year":"2005","journal-title":"Neurotox Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.pneurobio.2015.12.009","article-title":"Involvement of the kynurenine pathway in the pathogenesis of Parkinson's disease","volume":"155","author":"Lim","year":"2017","journal-title":"Prog Neurobiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/00004647-199806000-00002","article-title":"Quinolinic acid is increased in CSF and associated with mortality after traumatic brain injury in humans","volume":"18","author":"Sinz","year":"1998","journal-title":"J Cereb Blood Flow Metab."},{"key":"B50","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1089\/neu.2009.1120","article-title":"In situ detection of inflammatory mediators in post mortem human brain tissue after traumatic injury","volume":"27","author":"Frugier","year":"2010","journal-title":"J Neurotrauma"},{"key":"B51","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/WNR.0000000000001817","article-title":"Blast-related traumatic brain injury is mediated by the kynurenine pathway","volume":"33","author":"Zhang","year":"2022","journal-title":"Neuroreport."},{"key":"B52","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1136\/jnnp-2015-311369","article-title":"Mood symptoms correlate with kynurenine pathway metabolites following sports-related concussion","volume":"87","author":"Singh","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B53","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.bbi.2015.11.003","article-title":"Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder","volume":"53","author":"Meier","year":"2016","journal-title":"Brain Behav Immun."},{"key":"B54","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.bbi.2020.03.002","article-title":"Prospective study of the effects of sport-related concussion on serum kynurenine pathway metabolites","volume":"87","author":"Meier","year":"2020","journal-title":"Brain Behav Immun."},{"key":"B55","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.bbi.2020.11.011","article-title":"Positive association between serum quinolinic acid and functional connectivity following concussion","volume":"91","author":"Meier","year":"2021","journal-title":"Brain Behav Immun."},{"key":"B56","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1080\/16501960410023859","article-title":"Prognosis for mild traumatic brain injury: results of the WHO collaborating centre task force on mild traumatic brain injury","volume":"36","author":"Carroll","year":"2004","journal-title":"J Rehabilit Med."},{"key":"B57","article-title":"Neurocognitive and psychiatric symptoms following mild traumatic brain injury","volume-title":"Translational Research in Traumatic Brain Injury","author":"Cole","year":"2015"},{"key":"B58","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.biopsych.2021.05.021","article-title":"The kynurenine pathway in traumatic brain injury: Implications for psychiatric outcomes","volume":"91","author":"Meier","year":"2022","journal-title":"Biol Psychiatry."},{"key":"B59","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.biopsych.2021.07.023","article-title":"Emotion dysregulation following trauma: shared neurocircuitry of traumatic brain injury and trauma-related psychiatric disorders","volume":"91","author":"Weis","year":"2022","journal-title":"Biol Psychiatry."},{"key":"B60","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41398-023-02329-1","article-title":"Blood glutamate scavenging as a novel glutamate-based therapeutic approach for post-traumatic brain injury anxiety and social impairment","volume":"13","author":"Frank","year":"2023","journal-title":"Transl Psychiatry."},{"key":"B61","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jad.2006.07.013","article-title":"Kynurenine pathway in major depression: evidence of impaired neuroprotection","volume":"98","author":"Myint","year":"2007","journal-title":"J Affect Disord"},{"key":"B62","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-8-94","article-title":"Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?","volume":"8","author":"Steiner","year":"2011","journal-title":"J Neuroinflammation."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1126\/science.1835799","article-title":"NMDA antagonist neurotoxicity: mechanism and prevention","volume":"254","author":"Olney","year":"1991","journal-title":"Science."},{"key":"B65","doi-asserted-by":"publisher","first-page":"130","DOI":"10.2174\/138161211795049552","article-title":"Kynurenine pathway in schizophrenia: pathophysiological and therapeutic aspects","volume":"17","author":"Muller","year":"2011","journal-title":"Curr Pharm Des"},{"key":"B66","doi-asserted-by":"publisher","first-page":"10592","DOI":"10.1523\/JNEUROSCI.1107-14.2014","article-title":"Reduction of brain kynurenic acid improves cognitive function","volume":"34","author":"Kozak","year":"2014","journal-title":"J Neuroscience."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.bcp.2012.12.014","article-title":"Kynurenic acid as an antagonist of \u03b17 nicotinic acetylcholine receptors in the brain: facts and challenges","volume":"85","author":"Albuquerque","year":"2013","journal-title":"Biochem Pharmacol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1111\/ejn.12160","article-title":"Kynurenic acid, by targeting \u03b17 nicotinic acetylcholine receptors, modulates extracellular GABA levels in the rat striatum in vivo","volume":"37","author":"Beggiato","year":"2013","journal-title":"Eur J Neurosci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12974-023-02768-z","volume":"20","author":"Liu","year":"2023","journal-title":"J Neuroinflammation."},{"key":"B70","doi-asserted-by":"publisher","first-page":"440","DOI":"10.2174\/1871527316666170413110605","article-title":"Abnormalities in kynurenine pathway metabolism in treatment-resistant depression and suicidality: a systematic review","volume":"16","author":"Serafini","year":"2017","journal-title":"CNS & Neurol Dis."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1007\/s11011-018-0290-7","article-title":"IDO and TDO as a potential therapeutic target in different types of depression","volume":"33","author":"Qin","year":"2018","journal-title":"Metab Brain Dis."},{"key":"B72","doi-asserted-by":"publisher","first-page":"107746","DOI":"10.1016\/j.pharmthera.2020.107746","article-title":"Indoleamine and tryptophan 2, 3-dioxygenases as important future therapeutic targets","volume":"221","author":"Dol\u0161ak","year":"2021","journal-title":"Pharmacol Ther."},{"key":"B73","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry."},{"key":"B74","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1177\/02698811211026426","article-title":"Ketamine's effect on inflammation and kynurenine pathway in depression: a systematic review","volume":"35","author":"Kopra","year":"2021","journal-title":"J Psychopharmacol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e918","DOI":"10.1038\/tp.2016.200","article-title":"Neurotoxic kynurenine metabolism is increased in the dorsal hippocampus and drives distinct depressive behaviors during inflammation","volume":"6","author":"Parrott","year":"2016","journal-title":"Transl Psychiatry"},{"key":"B76","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/00001756-199612200-00004","article-title":"Facilitated brain uptake of 4-chlorokynurenine and conversion to 7-chlorokynurenic acid","volume":"8","author":"Hokari","year":"1996","journal-title":"Neuroreport."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1210453\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T05:14:24Z","timestamp":1686287664000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1210453\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,9]]},"references-count":76,"alternative-id":["10.3389\/fneur.2023.1210453"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1210453","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,9]]},"article-number":"1210453"}}